BUY Sun Pharmaceutical Industries Ltd. — Gaurav Sharma
byGaurav SharmaHorizon: NA (inferred Swing (≤2wk))19 Aug 2026via CNBC Awaaz.
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
1 other SEBI-registered advisor has an active swing BUY call on this stock, issued in the last 14 days
Advisor consensus · same horizon·31 Aug · today
Sun Pharma and its subsidiaries have won an antitrust litigation in the US related to the Lipitor patent settlement. The US Court of Appeals affirmed a summary judgment in their favor, denying class c
BSE · Company Update·17 Aug · 2w ago
2 advisors have active short-term BUY calls on this stock
Advisor consensus · adjacent horizon·30 Jul · 1mo ago
Nothing found in this tip’s window yet.
Nothing found in this tip’s window yet.
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

